HEDVATI; Lilach

Patent Applications and Registrations

Patent applications and USPTO patent grants for HEDVATI; Lilach.The latest application filed is for "raltegravir salts and crystalline forms thereof".

Company Profile

0.10.34

HEDVATI; Lilach - Doar Na Hefer IL
Hedvati; Lilach - Ein-Shemer IL
Hedvati; Lilach - Doar Ha Hefer IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Raltegravir Salts And Crystalline Forms Thereof App 20140256755 - KWOKAL; Ana ; et al.	2014-09-11
Raltegravir salts and crystalline forms thereof Grant 8,722,722 - Kwokal , et al. May 13, 2	2014-05-13
Raltegravir Salts and Crystalline Forms Thereof App 20130096147 - KWOKAL; Ana ; et al.	2013-04-18
Raltegravir Salts And Crystalline Forms Thereof App 20130079360 - Kwokal; Ana ; et al.	2013-03-28
Method for the preparation of Pregabalin and salts thereof Grant 7,763,749 - Hedvati , et al. July 27, 2	2010-07-27
Preparation of Retapamulin via its Pleuromutilin-thiol precursor App 20100184987 - Jaber; Nimer ; et al.	2010-07-22
Stereoselective Enzymatic Synthesis Of (s) Or (r)-iso-butyl-glutaric Ester App 20100087525 - Hedvati; Lilach ; et al.	2010-04-08
Purification of olmesartan medoxomil App 20100076200 - Hedvati; Lilach ; et al.	2010-03-25
Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid Grant 7,678,938 - Hedvati , et al. March 16, 2	2010-03-16
Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid Grant 7,619,112 - Hedvati , et al. November 17, 2	2009-11-17
Amorphous retapamulin and processes for preparation thereof App 20090234125 - Lancry; Eli ; et al.	2009-09-17
Olmesartan medoxomil with reduced levels of impurities App 20090209603 - Hedvati; Lilach ; et al.	2009-08-20
Olmesartan medoxomil with reduced levels of impurities Grant 7,563,814 - Hedvati , et al. July 21, 2	2009-07-21
Process for the preparation of Retapamulin and its intermediates App 20090149655 - Hedvati; Lilach ; et al.	2009-06-11
Pregabalin -4-eliminate, Pregabalin 5-eliminate, Their Use As Reference Marker And Standard, And Method To Produce Pregabalin Containing Low Levels Thereof App 20090137842 - VOLLERNER; Yuri ; et al.	2009-05-28
Preparation of olmesartan medoxomil Grant 7,528,258 - Hedvati , et al. May 5, 2	2009-05-05
Pregabalin free of lactam and a process for preparation thereof Grant 7,488,846 - Hedvati , et al. February 10, 2	2009-02-10
Processes for the preparation of R-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof Grant 7,462,738 - Hedvati , et al. December 9, 2	2008-12-09
Pregabalin free of isobutylglutaric acid and a process for preparation thereof Grant 7,462,737 - Hedvati , et al. December 9, 2	2008-12-09
Crystalline forms of pregabalin Grant 7,417,165 - Aronhime , et al. August 26, 2	2008-08-26
Amorphous and crystalline forms of pantoprazole magnesium salt App 20080139623 - Hedvati; Lilach ; et al.	2008-06-12
Polymorphic forms of ziprasidone HCI and processes for their preparation App 20080091020 - Koltai; Tamas ; et al.	2008-04-17
Polymorphic forms of ziprasidone HCl and processes for their preparation App 20080090835 - Koltai; Tamas ; et al.	2008-04-17
Use of enzymatic resolution for the preparation of intermediates of pregabalin App 20080026433 - Hedvati; Lilach ; et al.	2008-01-31
Preparation of (S)-pregabalin-nitrile App 20080015385 - Hedvati; Lilach	2008-01-17
Processes for the preparation of R-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof App 20070293694 - Hedvati; Lilach ; et al.	2007-12-20
Optical resolution of-3-carbamoylmethyl-5-methyl hexanoic acid App 20070287748 - Hedvati; Lilach ; et al.	2007-12-13
Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid App 20070287859 - Hedvati; Lilach ; et al.	2007-12-13
Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid App 20070287860 - Hedvati; Lilach ; et al.	2007-12-13
Method for the preparation of pregabalin and salts thereof App 20070073085 - Hedvati; Lilach ; et al.	2007-03-29
Process for making (S)-Pregabalin App 20070066846 - Maymon; Asher ; et al.	2007-03-22
Purification of olmesartan medoxomil App 20070054948 - Hedvati; Lilach ; et al.	2007-03-08
Optical resolution of 3-carbamoylmethyl-5-methylhexanoic acid App 20070043241 - Hedvati; Lilach ; et al.	2007-02-22
Pregabalin free of lactam and a process for preparation thereof App 20060281816 - Hedvati; Lilach ; et al.	2006-12-14
Pregabalin free of isobutylglutaric acid and a process for preparation thereof App 20060276544 - Hedvati; Lilach ; et al.	2006-12-07
Crystalline forms of pregabalin App 20060276543 - Aronhime; Judith ; et al.	2006-12-07
Olmesartan medoxomil with reduced levels of impurities App 20060258727 - Hedvati; Lilach ; et al.	2006-11-16
Process for preparing olmesartan medoxomil AT pH higher than 2.5 App 20060148870 - Hedvati; Lilach ; et al.	2006-07-06
Olmesartan medoxomil with reduced levels of impurities App 20060149078 - Hedvati; Lilach ; et al.	2006-07-06
Purification of olmesartan medoxomil App 20060074117 - Hedvati; Lilach ; et al.	2006-04-06
Preparation of olmesartan medoxomil App 20060069141 - Hedvati; Lilach ; et al.	2006-03-30
Polymorphic forms of ziprasidone HCI and processes for their preparation App 20050043324 - Koltai, Tamas ; et al.	2005-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.